PedAM
Pediatric Disease Annotations & Medicines
| Disease | breast cancer |
| Symptom | C0494165|liver metastases |
| Sentences | 23 |
| PubMedID- 22312487 | This is one of the largest series of breast cancer patients with liver metastases treated with tace. |
| PubMedID- 24719119 | Therefore, we reviewed the outcome of liver resection in breast cancer patients with liver metastases in a single hospital experiences. |
| PubMedID- 20409335 | The second feature is of occult liver metastases due to breast cancer. |
| PubMedID- 22682709 | Resection of liver metastases in patients with breast cancer: survival and prognostic factors. |
| PubMedID- 25885919 | In tumor-bearing mice, cc chemokine ligand 2 (ccl2) neutralizing antibodies inhibit the growth and liver metastases of primary breast cancer by reducing cell proliferation, survival, and tumor-associated macrophage (tam) recruitment. |
| PubMedID- 26395067 | For breast cancer patients with liver metastases, if the patient was found to have “primary” liver cancer before surgery, fmi-guided surgery using the her2 probe will identify the true primary tumour in the breast during surgery and increase the precision of cancer surgery. |
| PubMedID- 23411960 | Successful treatment of trastuzumab-resistant her2-positive breast cancer with extensive liver metastases using the combination of trastuzumab and capecitabine - a case report. |
| PubMedID- 24073730 | Percutaneous radiofrequency ablation for liver metastases in breast cancer patients. |
| PubMedID- 19657653 | Tace is an optional therapy for treatment of liver metastases in breast cancer patients with better results from the combined chemotherapy protocol. |
| PubMedID- 25598217 | In liver metastases of breast cancer, claudin-2 expression was found to be elevated in comparison to primary tumour 72,73. in kidney proximal tubule, claudin-2 is expressed in high level 74. haplo-insufficiency of claudin-2 gene mice has reduced reabsorption of na+ in the proximal tubule. |
| PubMedID- 26131746 | Resection of liver metastases in breast cancer. |
| PubMedID- 20647719 | We experienced a case of anthracycline- and taxane-resistant recurrent breast cancer with multiple liver metastases and multiple bone metastases showing marked improvement by s-1. |
| PubMedID- 26020523 | Long-term survival of a breast cancer patient with extensive liver metastases upon immune and virotherapy: a case report. |
| PubMedID- 25356184 | In this article we report a case of male breast cancer with liver metastases, which showed a good response to a combined treatment of bevacizumb and paclitaxel, suggesting a useful option for the first-line treatment of patients with recurrent her2-negative male breast cancer. |
| PubMedID- 21281746 | liver metastases in breast cancer are common and a small number of those patients may be suitable for surgical resection. |
| PubMedID- 20332694 | A 51-year-old patient had recurrent breast cancer with liver metastases. |
| PubMedID- 21160266 | We report a case of multi-drug-resistant breast cancer with liver metastases which completely responded and improved the quality of life (qol)by s-1 monotherapy. |
| PubMedID- 24196076 | A case of recurrent breast cancer with liver metastases showing good response to combination therapy with s-1 plus trastuzumab. |
| PubMedID- 22285778 | Background: the oncologic benefit of resecting liver metastases in patients with breast cancer is unclear. |
| PubMedID- 25241752 | Case presentation: we report here the unique observation of the spontaneous evolution of two breast cancer patients with synchronous liver metastases who decided to stop trastuzumab after achieving complete response. |
| PubMedID- 26457338 | Seeding after ultrasound-guided percutaneous biopsy of liver metastases in patients with colorectal or breast cancer. |
| PubMedID- 22295241 | In a study by stessels et al., 43 out of 45 breast cancer cases examined with liver metastases exhibited what is known as replacement growth, where tumor cells displace hepatocytes to coopt the sinusoidal blood vessels while preserving liver architecture . |
| PubMedID- 19705049 | Bronj appeared in a 61-year-old female carrying breast cancer with bone and liver metastases on dental extraction on may 29, 2007 after intravenous zoledronate (4 mg/month) over a period of 1 year and 4 months. |
Page: 1